Impact of pravastatin on secondary prevention of coronary artery disease in normolipidemic patients: Prospective randomized trial (PCS study)

被引：0
|
作者：
Kirino, M
Sato, S
Kobayashi, T
Nakagawa, Y
Hiraoka, H
Katoh, O
Shibata, N
Awata, N
Kobayashi, T
Reiber, JHC
Zwinderman, AH
机构：
[1] Osaka Med Ctr, Osaka, Japan
[2] Osaka Univ, Sch Med, Osaka, Japan
[3] Osaka Med Coll, Osaka, Japan
[4] Leiden Univ, Med Ctr, Leiden, Netherlands
来源：
CIRCULATION | 1998年 / 98卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2807
引用
收藏
页码：534 / 534
页数：1
相关论文
共 50 条
  • [21] Efficacy of participatory education as compared to clinical guidelines in secondary prevention of patients with coronary artery disease: A randomized study
    Kiessling, A
    Henriksson, P
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) : 435A - 435A
  • [22] Impact of early statin initiation on secondary prevention in Japanese patients with coronary artery disease
    Nakamura, Michinari
    Yamashita, Takeshi
    Yajima, Junji
    Oikawa, Yuji
    Ogasawara, Ken
    Sagara, Koichi
    Koike, Akira
    Kirigaya, Hajime
    Nagashima, Kazuyuki
    Otsuka, Takayuki
    Uejima, Tokuhisa
    Funada, Ryuichi
    Matsuno, Shunsuke
    Suzuki, Shinya
    Sawada, Hitoshi
    Aizawa, Tadanori
    JOURNAL OF CARDIOLOGY, 2011, 57 (02) : 172 - 180
  • [23] What is the role of pravastatin for secondary prevention in coronary heart disease?
    Mahé, I
    PRESSE MEDICALE, 1999, 28 (13): : 691 - 691
  • [24] ECONOMIC EVALUATION OF PRAVASTATIN FOR THE PREVENTION OF CORONARY ARTERY DISEASE IN JAPAN
    Onishi, Y.
    Hinotsu, S.
    Nakao, Y. M.
    Urushihara, H.
    Kawakami, K.
    VALUE IN HEALTH, 2011, 14 (07) : A378 - A378
  • [25] Secondary Prevention of Coronary Artery Disease
    Hall, Scott L.
    Lorenc, Todd
    AMERICAN FAMILY PHYSICIAN, 2010, 81 (03) : 289 - 296
  • [26] The secondary prevention of coronary artery disease
    Merz, CNB
    Rozanski, A
    Forrester, JS
    AMERICAN JOURNAL OF MEDICINE, 1997, 102 (06): : 572 - 581
  • [27] Secondary prevention for coronary artery disease
    McLeod, AL
    Brooks, L
    Taylor, V
    Currie, PF
    Dewhurst, NG
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2004, 97 (03) : 127 - 131
  • [28] PRAVASTATIN LOWERS CHOLESTEROL AND APPEARS TO DECREASE TRANSPLANT CORONARY-ARTERY DISEASE - A RANDOMIZED TRIAL
    KOGASHIGAWA, JA
    CARR, JG
    MORIGUCHI, JD
    GLEESON, MP
    YEATMAN, L
    TROSIAN, K
    SHEN, T
    KAWATA, N
    HAMILTON, MA
    HAGE, A
    DRINKWATER, D
    LAKS, H
    CIRCULATION, 1994, 90 (04) : 94 - 94
  • [29] Eicosapentaenoic and docosahexaenoic acid supplementation and coronary artery calcium progression in patients with coronary artery disease: A secondary analysis of a randomized trial
    Hariri, Essa
    Asbeutah, Abdul Aziz
    Malik, Abdulaziz
    Amangurbanova, Maral
    Chedid, Georges
    Daher, Ralph
    Al Hammoud, Mazen
    Welty, Francine K.
    ATHEROSCLEROSIS, 2023, 387
  • [30] Azithromycin for the secondary prevention of coronary heart disease events - The WIZARD study: A randomized controlled trial
    O'Connor, CM
    Dunne, MW
    Pfeffer, MA
    Muhlestein, JB
    Yao, L
    Gupta, S
    Benner, RJ
    Fisher, MR
    Cook, TD
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (11): : 1459 - 1466
12345